Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
4.500
+0.040 (0.90%)
At close: Jan 21, 2025, 4:00 PM
4.590
+0.090 (2.00%)
After-hours: Jan 21, 2025, 5:01 PM EST
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $2.25 million as of January 21, 2025. Its market cap has decreased by -27.37% in one year.
Market Cap
2.25M
Enterprise Value
28.47K
1-Year Change
-27.37%
Ranking
Category
Stock Price
$4.50
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $161.90M to $2.25M, a decrease of -98.61%. That is a compound annual growth rate of -39.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 2.20M | - |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.43% |
| Dec 31, 2021 | 38.60M | -74.59% |
| Dec 31, 2020 | 151.90M | 413.18% |
| Dec 31, 2019 | 29.60M | 2.78% |
| Dec 31, 2018 | 28.80M | -68.28% |
| Dec 29, 2017 | 90.80M | 83.81% |
| Dec 30, 2016 | 49.40M | -69.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |